1 – Program overview

The program is designed to assess the performance of different serological tests for Lyme disease: IgG/IgM screening tests and IgG/IgM confirmation tests.

Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the program.

2 – Assessment frequency

Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6

3 – List of tests assessed

• IgG and IgM screening tests
• IgG and IgM confirmation tests
• Interpretation

4 – Description of the control samples

Lyophilized human control serums (samples to be resuspended in 1 mL of distilled water).

5 - Clinical settings

The clinical setting for the samples to be tested during each survey is systematically described and participating labs are encouraged to propose a global interpretation of the results obtained. This interpretation is also commented in the reports.